Research Output per year
Personal profile
Area of Expertise
Dr. Jann’s research interests are in pharmacogenomics, pharmacokinetics, and pharmacodynamics of CNS and other molecules in clinical research.
Education/Academic qualification
PharmD, University of Southern California
BS in Biology, California State University Los Angeles
Fingerprint Dive into the research topics where Michael Jann is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 5 Similar Profiles
Haloperidol
Medicine & Life Sciences
Pharmacokinetics
Medicine & Life Sciences
Clozapine
Medicine & Life Sciences
Antipsychotic Agents
Medicine & Life Sciences
Pharmaceutical Preparations
Medicine & Life Sciences
Drug Interactions
Medicine & Life Sciences
olanzapine
Medicine & Life Sciences
Schizophrenia
Medicine & Life Sciences
Network
Recent external collaboration on country level. Dive into details by clicking on the dots.
Research Output 1980 2019
An elective course in lesbian, gay, bisexual, and transgender health and practice issues
Jann, M. W., Penzak, S., White, A. & Tatachar, A., 1 Jan 2019, In : American journal of pharmaceutical education. 83, 8, p. 1723-1731 9 p., 6967.Research output: Contribution to journal › Article
Transgender Persons
Health
health
health care
learning
2
Citations
(Scopus)
Selective serotonin reuptake inhibitor use and risk of gastrointestinal and intracranial bleeding
Yuet, W. C., Derasari, D., Sivoravong, J., Mason, D. & Jann, M., Feb 2019, In : Journal of the American Osteopathic Association. 119, 2, p. 102-111 10 p.Research output: Contribution to journal › Review article
Serotonin Uptake Inhibitors
Hemorrhage
clopidogrel
Gastrointestinal Tract
Osteopathic Physicians
The Evolving Role of Pharmacists in Transgender Health Care
Redfern, J. S. & Jann, M. W., 11 Apr 2019, In : Transgender Health. 4, 1, p. 118-130 13 p.Research output: Contribution to journal › Review article
Open Access
Transgender Persons
pharmacist
Pharmacists
health care
Delivery of Health Care
Correction to: Long-Acting Injectable Second-Generation Antipsychotics: An Update and Comparison Between Agents (CNS Drugs, (2018), 32, 3, (241-257), 10.1007/s40263-018-0508-6)
Jann, M. W. & Penzak, S. R., 1 Jun 2018, In : CNS Drugs. 32, 6, 1 p.Research output: Contribution to journal › Comment/debate
Antipsychotic Agents
Injections
Pharmaceutical Preparations
Schizophrenia
Pharmacokinetics
7
Citations
(Scopus)
Long-Acting Injectable Second-Generation Antipsychotics: An Update and Comparison Between Agents
Jann, M. W. & Penzak, S. R., 1 Mar 2018, In : CNS Drugs. 32, 3, p. 241-257 17 p.Research output: Contribution to journal › Review article
Antipsychotic Agents
Injections
olanzapine
Risperidone
Patient Education